Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health
issue with an unmet medical need for therapy. This disease is featured by a progressive …

Background: Abdominal aortic aneurysm (AAA), a progressive segmental abdominal aortic
dilation, is associated with high mortality. AAA is characterized by inflammation, smooth …

OBJECTIVE: To determine whether statin therapy reduces the growth rate of small
abdominal aortic aneurysms (AAAs). DESIGN: A meta-analysis and a meta-regression of …

Background Patients undergoing vascular surgery are a high‐risk population with
widespread atherosclerosis, an adverse cardiovascular risk profile and often multiple co …

Guidelines from the American College of Cardiology/American Heart Association
(ACC/AHA) and the UK National Institute for Health and Care Excellence (NICE) indicate …

2861 Medical Treatment for Abdominal Aortic Aneurysm ical treatments include anti-
hypertensives, statins, and antibiotics, some of which might work as MMP inhibitors. Tables …

Background The relationship between numerous risk factors and perioperative mortality
after cardiovascular surgery has been studied extensively. While improved perioperative …

Aortic aneurysms are a complex genetic disorder with known environmental risk factors such
as smoking. Along the length of the aorta, significant heterogeneity occurs in the distribution …

Background Despite the importance of the renin-angiotensin (Ang) system in abdominal
aortic aneurysm (AAA) pathogenesis, strategies targeting this system to prevent clinical …

Objective Although the endovascular aneurysm repair trial 2 (EVAR-2) demonstrated no
benefit of EVAR in high-risk (HR) patients, EVAR is still performed widely in this patient …